FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: SLXP

Sort
E.g., 2013-05-23
E.g., 2013-05-23
Enter a comma separated list of user names.

Last year at this time, I made a screen of some stocks from the healthcare sector with an interesting market valuation, a great past growth performance as well as good earnings situation. Such stocks had a forward price to earnings ratio of less than 15, a sales growth over the past five years of more than 10 percent as well as an operating margin above 10 percent. Exactly seven stocks fulfilled these criteria. Now, I review these picks and try to discover a new list of potential stocks for next year, 2013. Over the recent year the Dow is up 8.36 percent, the S&P 500 gained 13.82 percent and the NASDAQ is 14.58 percent higher. My seven healthcare picks performed in average 31.55 percent while the healthcare sector gained 25.7 percent. Below is a current screen of the seven picks.

Salix Pharmaceuticals, Ltd (NASDAQ:SLXP) is a pharmaceutical company engaged in acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract.

Salix Pharmaceuticals, Ltd (NASDAQ:SLXP) is a pharmaceutical company engaged in acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract.

Salix Pharmaceuticals, Ltd (NASDAQ:SLXP) achieved its new 52 week high price of $49.87 where it was opened at $49.46 UP 0.20 points or +0.41% by closing at $49.56. SLXP transacted shares during the day were over 593,767 shares however it has an average volume of 814,003 shares.

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced that the Company will present at The 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 11, 2012 at 4:30 p.m. PT (7:30 p.m. ET). Interested parties can access a live audio web cast of the presentation at http://www.salix.com. A replay of the presentation will be available at the same location.

Tags:

Crown Equity Holdings Inc., (CRWE)

Crown Equity Holdings Inc. (CRWE.OB) announced that it has launched CRWE Tube, www.crwetube.com, a video sharing site that allows billions of people around the world to upload watch and share original videos.

Tags:

Salix Pharmaceuticals, Ltd (NASDAQ:SLXP) Salix Pharmaceuticals, Ltd. is a pharmaceutical company engaged in acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract.

MSHL, Marshall Edwards Inc.

** MSHL reported that the U.S. Patent and Trademark Office has issued a new patent, U.S. Patent No. 8,080,675, covering a number of the Company's isoflavone-based compounds, including lead oncology-drug candidates ME-143 and ME-344, and their pharmaceutical compositions. The patent is estimated to provide protection until March 2027.

Pages

ADVERTISE WITH US